Giant Biogene Holding Co., Ltd.

SEHK:2367 Stock Report

Market Cap: HK$50.3b

Giant Biogene Holding Past Earnings Performance

Past criteria checks 6/6

Giant Biogene Holding has been growing earnings at an average annual rate of 21.1%, while the Personal Products industry saw earnings growing at 10% annually. Revenues have been growing at an average rate of 49.4% per year. Giant Biogene Holding's return on equity is 29.5%, and it has net margins of 39.7%.

Key information

21.1%

Earnings growth rate

21.2%

EPS growth rate

Personal Products Industry Growth8.8%
Revenue growth rate49.4%
Return on equity29.5%
Net Margin39.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue Beat: Giant Biogene Holding Co., Ltd. Beat Analyst Estimates By 12%

Aug 21
Revenue Beat: Giant Biogene Holding Co., Ltd. Beat Analyst Estimates By 12%

Does Giant Biogene Holding (HKG:2367) Deserve A Spot On Your Watchlist?

Aug 09
Does Giant Biogene Holding (HKG:2367) Deserve A Spot On Your Watchlist?

Giant Biogene Holding Co., Ltd.'s (HKG:2367) Popularity With Investors Is Clear

Jul 01
Giant Biogene Holding Co., Ltd.'s (HKG:2367) Popularity With Investors Is Clear

Is Giant Biogene Holding Co., Ltd. (HKG:2367) Trading At A 32% Discount?

Apr 17
Is Giant Biogene Holding Co., Ltd. (HKG:2367) Trading At A 32% Discount?

Investors Interested In Giant Biogene Holding Co., Ltd.'s (HKG:2367) Earnings

Mar 28
Investors Interested In Giant Biogene Holding Co., Ltd.'s (HKG:2367) Earnings

Giant Biogene Holding Co., Ltd. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next

Mar 27
Giant Biogene Holding Co., Ltd. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next

Do Giant Biogene Holding's (HKG:2367) Earnings Warrant Your Attention?

Dec 24
Do Giant Biogene Holding's (HKG:2367) Earnings Warrant Your Attention?

A Look At The Intrinsic Value Of Giant Biogene Holding Co., Ltd. (HKG:2367)

Oct 30
A Look At The Intrinsic Value Of Giant Biogene Holding Co., Ltd. (HKG:2367)

Giant Biogene Holding Co., Ltd.'s (HKG:2367) Share Price Matching Investor Opinion

Mar 28
Giant Biogene Holding Co., Ltd.'s (HKG:2367) Share Price Matching Investor Opinion

Revenue & Expenses Breakdown

How Giant Biogene Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:2367 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 244,4591,7681,61690
31 Mar 243,9921,6101,43882
31 Dec 233,5241,4521,26075
30 Sep 233,2551,2521,18367
30 Jun 232,9851,0521,10659
31 Mar 232,67587496252
31 Dec 222,36469681844
31 Dec 211,55280941925
31 Dec 201,19082618713
31 Dec 1995755212211

Quality Earnings: 2367 has high quality earnings.

Growing Profit Margin: 2367's current net profit margins (39.7%) are higher than last year (35.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2367's earnings have grown significantly by 21.1% per year over the past 5 years.

Accelerating Growth: 2367's earnings growth over the past year (68.1%) exceeds its 5-year average (21.1% per year).

Earnings vs Industry: 2367 earnings growth over the past year (68.1%) exceeded the Personal Products industry 48.8%.


Return on Equity

High ROE: 2367's Return on Equity (29.5%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies